Brandywine Global Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-478,605
| Closed | -$5.48M | – | 721 |
|
|
2023
Q4 | $5.48M | Buy |
478,605
+2,046
| +0.4% | +$23.4K | 0.04% | 376 |
|
|
2023
Q3 | $4.59M | Sell |
476,559
-5,429
| -1% | -$52.3K | 0.04% | 387 |
|
|
2023
Q2 | $5.13M | Buy |
481,988
+227,937
| +90% | +$2.43M | 0.04% | 373 |
|
|
2023
Q1 | $2.67M | Buy |
+254,051
| New | +$2.67M | 0.02% | 506 |
|
|
2022
Q4 | – | Sell |
-206,221
| Closed | -$2.14M | – | 754 |
|
|
2022
Q3 | $2.14M | Sell |
206,221
-9,640
| -4% | -$99.8K | 0.02% | 530 |
|
|
2022
Q2 | $2.49M | Sell |
215,861
-11,849
| -5% | -$137K | 0.02% | 490 |
|
|
2022
Q1 | $2.87M | Buy |
227,710
+12,956
| +6% | +$163K | 0.02% | 478 |
|
|
2021
Q4 | $2.5M | Hold |
214,754
| – | – | 0.02% | 499 |
|
|
2021
Q3 | $2.81M | Buy |
+214,754
| New | +$2.81M | 0.02% | 486 |
|